Corcept Therapeutics CORT today announced the appointment of Gary C. Robb to the position of Chief Financial Officer, effective September 1, 2011. Mr. Robb will oversee Corcept's financial operations, including preparations for potential commercialization of our first product, business development activities, investor relations, and along with other members of the management team, corporate strategy.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in